SCLX Q1 2024 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q1 2024 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$11M+2.9% YoY

Gross Profit

$7M64.7% margin

Operating Income

-$19M-179.0% margin

Net Income

-$24M-224.0% margin

EPS (Diluted)

$-6.69

QoQ Revenue Growth

-19.2%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$9M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$91M

Total Liabilities

$281M

Stockholders' Equity

-$190M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$11M	+2.9%
Gross Profit	$7M	$7M	+0.8%
Operating Income	-$19M	-$25M	+23.5%
Net Income	-$24M	-$31M	+20.7%